SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

BMO Capital Maintains Outperform on Moderna, Raises Price Target to $112

BMO Capital maintains Moderna (NASDAQ:MRNA) with a Outperform and raises the price target from $83 to $112.

Benzinga · 05/19/2020 14:00

BMO Capital maintains Moderna (NASDAQ:MRNA) with a Outperform and raises the price target from $83 to $112.